GMP News - Analytical Quality Control

16.01.13

Analytical Balances: New USP Proposals on Qualification

The US American Pharmacopoeia USP has informed about its plan to replace the title of General Chapter <41> "Weights and Balances" by "Balances" and also to revise General Chapter <1251> "Weighing on an Analytical Balance". More details about the current proposals regarding the qualification of analytical balances can be found here in the News.

more

09.01.13

Significant Guidelines regarding Veterinary Medicinal Products

Five new documents have been published by the EMA for manufacturers of veterinary medicinal products, including the VICH Guideline Draft on Statistical Evaluation of Stability Data. Read more here about these documents published for veterinary use.

more

19.12.12

New USP Publication: Monitoring Humidity during Transportation?

What are the risks of humidity excursions during transportation of products (medicinal products, APIs, intermediates)? A current publication in the USP Pharmacopeial Forum has examined the question. Read more here about the USP article.

more

05.12.12

USP Postpones the Publication of General Chapters <232> and <233> on Metallic Impurities

The introduction of the USP chapters in metallic impurities originally planned for 1st December 2012 has been postponed. Read more here about USP's reasons for that decision.

more

14.11.12

New EMA Q&As on Genotoxic Impurities

In June 2012 the EMA posted a new question in the Q&A part on quality of medicines regarding how to set specifications for genotoxic and potentially genotoxic impurities. Read more.

more

07.11.12

New EMA Guideline on Specifications for Impurities in Antibiotics

A new EMA Guideline on impurities of APIs manufactured by fermentation with eventual further synthetic steps defines precise requirements with regard to the information that has to be provided on these impurities. Read more here in the News.

more

01.10.12

FDA Dissolution Methods Database

FDA aids the pharmaceutical industry in developing generic drug products by providing a database on methods for active drug dissolution testing. The most important functions are described in the FDA document "Frequently Asked Questions". You can obtain more information in this news.

more

19.09.12

Dissolution Testing of new and special Dosage Forms - Updated FIP/AAPS Document

Due to the rapid evolution of new practices and techniques for dissolution/drug release testing, FIP decided to revise the previous position paper from 2003. Get further information.

more

12.09.12

USP Standard for Dissolution Testing withdrawn

USP has withdrawn a standard for the Apparatus 3 Performance Verification Test for dissolution testing as of February 2012. Get more information, also about the background - in this news.

more

22.08.12

Curved Calibration Functions - how to perform the Regression Calculation?

For curved calibration functions there exists some uncertainty how to establish a calibration which is in conformity with DIN/ISO standards. In this news you will be informed about new possibilities for performing the corresponding calculations.

more

22.08.12

FDA Expectations concerning Real Time Release Testing (RTRT)

The FDA has highlighted the importance of Real Time Release Testing (RTRT) in a publication. It explicitly supports the implementation of RTRT approaches in the pharmaceutical industry.  When RTRT is used, it is part of the control strategy and can include some or all of the final critical quality attributes (CQAs). Please click here to obtain more information in this news.

more

22.08.12

New EMA draft on NIRS

The EMA has published the draft for a Guideline on the use of Near Infrared Spectroscopy (NIRS) in January 2012. NIRS is one of the most important technologies in PAT applications. The guideline deals with qualitative and quantitative procedures. You can obtain more information in this news.

more

22.08.12

USP Article about new USP NIR System Suitability Reference Standard

In an article of the USP Pharmacopeial Forum, the authors give reasons why the continued use of the USP NIR System Suitability Reference Standard is recommended. More about the USP article and the verification of wavelengths of NIRS systems by calibration standards can be found here.

more

22.08.12

New EMA Guideline on Real Time Release Testing

The concept of parametric release has been primarily used for the sterility testing of products terminally sterilised. Now, the new EMA Guideline will extend this alternative release strategy - Real Time Release Testing - to all types of APIs and finished products testing. Read more here in the News.

more

25.07.12

How to set Specifications for Genotoxic, Metallic Impurities and Residual Solvents in APIs?

The EMA has recently extended its Questions and Answers collection with three statements regarding the setting of drug substance specifications for potentially genotoxic, metallic impurities, and solvent residues. More details here.

more

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics